Menu
Home
About
About Us
Our Team
Publications
Platform
CAR-γδ T Cell
iPSC-γδ NKT Cell
Pipeline
Manufacturer
Investors
Contact Us
Shareholder Benefits
Make An Appointment
Chimeric switch receptor: switching for improved adoptive T-cell therapy against cancers
«
Expansion of gamma delta T cells – a short review on bisphosphonate and K562-based methods
Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
»